Orphan drug status granted to Restanza for plague and tularemia - MPR
Links shared publicly online about this topic.
- 1,746total visits
Orphan drug status granted to Restanza for plague and tularemia - MPR
empr.com —
Advanced Life Sciences Holdings announced that the FDA has granted Orphan Drug Designation to Restanza (cethromycin), its once daily oral antibiotic, for the prophylactic treatment of plague and tularemia.
View full resource at empr.com
Tags: Plague, Tularemia, Drug, FDA, Antibiotic, News, Science
Most Recently Shared on September 15, 2009 at 7:26 pm By:
MPR News: Orphan drug status granted to Restanza for plague and tularemia: Advanced Life Sciences Holdi.. http://bit.ly/BYtyn
Advertisement
